Dianthus Therapeutics (DNTH) Payables (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Payables of $9.7 million for Q4 2025, up 112.38% year-over-year from $4.6 million in Q4 2024, and up 45.04% quarter-over-quarter from $6.7 million in Q3 2025.
Dianthus Therapeutics (DNTH) Payables (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Payables history runs 9 years deep, the most recent figure standing at $9.7 million for Q4 2025.
- In Q4 2025, Payables rose 112.38% year-over-year to $9.7 million; the TTM figure through Dec 2025 stood at $9.7 million (up 112.38% YoY), while the FY2025 annual figure was $9.7 million, up 112.38% from the prior year.
- Payables for Q4 2025 stood at $9.7 million, up from $6.7 million in the prior quarter.
- The five-year high for Payables was $9.7 million in Q4 2025, with the low at $813000.0 in Q2 2023.
- The 5-year median for Payables is $2.8 million (2021), against an average of $3.7 million.
- The sharpest annual moves came in 2023 and 2024: Payables plunged 75.66% in 2023, then jumped 453.1% in 2024.
- Dianthus Therapeutics' Payables stood at $3.0 million in 2021, then slumped by 61.61% to $1.2 million in 2022, then surged by 123.65% to $2.6 million in 2023, then soared by 75.44% to $4.6 million in 2024, then jumped by 112.38% to $9.7 million in 2025.
- Business Quant data shows DNTH's Payables at $9.7 million in Q4 2025, $6.7 million in Q3 2025, and $5.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | 9.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.73 Mn |
| Sep 30, 2025 | 6.71 Mn |
| Jun 30, 2025 | 5.40 Mn |
| Mar 31, 2025 | 8.27 Mn |
| Dec 31, 2024 | 4.58 Mn |
| Sep 30, 2024 | 7.57 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | 2.61 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 813,000.00 |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.17 Mn |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 2.05 Mn |
| Mar 31, 2022 | 4.44 Mn |
| Dec 31, 2021 | 3.04 Mn |
| Sep 30, 2021 | 1.89 Mn |
| Jun 30, 2021 | 2.93 Mn |
| Mar 31, 2021 | 2.11 Mn |